There are some challenging things to consider and research for CAR-T:
- The high cost
https://www.webmd.com/cancer/lymphoma/features/navigate-finances-car-t-cell-therapy- Complexity of treatment administration (the greater the complexity, logically the greater the risk, complexity increases cost of trials and so on)
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/car-t-cell-therapy- The saturation of the market (the large number of treatments being developed) makes it hard for new products to secure market share
- Response rates in solid tumours have been limited and there have been significant safety hurdles
https://www.mdpi.com/2072-6694/14/23/5983
There are some challenging things to consider and research for...
-
- There are more pages in this discussion • 3,508 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
